← Eichor
Study identifier: NCT07508124 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Condition: Urinary Tract Infection  ·  Sponsor: Baylor College of Medicine

PhasePhase 4
Planned participants40
Who can joinMale, 0 Months to 5 Months
Healthy volunteersNo

About this study

The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.

This description comes directly from the study's public registry record.

Talk to the study team

Sowdhamini Wallace, DO, MS  ·  18328245447  ·  swallace@bcm.edu

Always discuss trial participation with your own doctor first.

Locations (3)

Texas Children's Hospital Main campusHouston, Texas, United StatesRecruiting
Texas Children's Hospital West CampusKaty, Texas, United StatesNot Yet Recruiting
Seattle Children's HospitalSeattle, Washington, United StatesNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07508124